Scarica l'app Stockscreener
6.75
1.05%
0.07
Dopo l'orario di chiusura:
6.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$6.68
Aprire:
$6.66
Volume 24 ore:
726.79K
Relative Volume:
0.50
Capitalizzazione di mercato:
$1.04B
Reddito:
$53.61M
Utile/perdita netta:
$-142.52M
Rapporto P/E:
-6.0811
EPS:
-1.11
Flusso di cassa netto:
$-141.83M
1 W Prestazione:
+8.17%
1M Prestazione:
-12.68%
6M Prestazione:
-53.25%
1 anno Prestazione:
+8.35%
Intervallo 1D:
$6.48
$6.86
Intervallo di 1 settimana:
$5.98
$6.86
Portata 52W:
$4.25
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Confronta WVE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
6.75 | 961.80M | 53.61M | -142.52M | -141.83M | -1.11 |
|
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Wedbush | Outperform |
| 2025-02-25 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Ripresa | JP Morgan | Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-09-09 | Iniziato | JP Morgan | Overweight |
| 2024-05-15 | Iniziato | Wells Fargo | Overweight |
| 2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Raymond James | Outperform |
| 2023-05-24 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-15 | Ripresa | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Iniziato | Guggenheim | Buy |
| 2019-07-15 | Iniziato | Cowen | Market Perform |
| 2019-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-08-07 | Iniziato | Stifel | Buy |
| 2018-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2017-02-15 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-07 | Iniziato | Jefferies | Buy |
| 2015-12-07 | Iniziato | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled By Investing.com - Investing.com South Africa
Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled - Investing.com Australia
Risks Still Elevated At These Prices As Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Dive 26% - simplywall.st
Nuveen Asset Management LLC Has $6.85 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference | WVE Stock News - GuruFocus
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewswire
Wave Life Sciences CEO Reveals Next-Gen RNA Medicine Plans at Major Healthcare Conference - Stock Titan
Wave Life Sciences Announces Appointment Of Dr. Christopher Wright As Chief Medical Officer - marketscreener.com
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WV - GuruFocus
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WVE Stock News - GuruFocus
WaVe Life Sciences’ SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Nigeria
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $648,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Bank of America Corp DE Acquires 160,820 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Deutsche Bank AG Purchases 25,756 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? - MSN
Preclinical data for Wave’s INHIBE GalNAc-siRNA in obesity - BioWorld MedTech
BNP Paribas Financial Markets Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of “Buy” by Analysts - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Increased by Northern Trust Corp - Defense World
(WVE) On The My Stocks Page - news.stocktradersdaily.com
FY2025 Earnings Estimate for WVE Issued By Cantor Fitzgerald - Defense World
Raymond James Financial Inc. Takes $157,000 Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com Australia
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock By Investing.com - Investing.com India
Wave Life Sciences (NASDAQ:WVE) Stock Rating Lowered by StockNews.com - Defense World
Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com
Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks
Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register
WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus
Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo
Wave Life Sciences (WVE) Misses Revenue Estimates, Advances Clinical Trials | WVE Stock News - GuruFocus
Wave Life Sciences Reports Q1 2025 Financial Results - TipRanks
WAVE LIFE SCIENCES Earnings Results: $WVE Reports Quarterly Earnings - Nasdaq
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Earnings Flash (WVE) Wave Life Sciences Reports Q1 Revenue $9.2M, vs. FactSet Est of $11.9M - marketscreener.com
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Wave Life Sciences Ltd Azioni (WVE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HENRY CHRISTIAN O | Director |
Mar 20 '25 |
Sale |
9.77 |
10,500 |
102,574 |
16,115 |
0.86%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):